Avai Bio, Inc.

AVAI OTC SEC CIK 1740797
Follow Avai Bio Weekly email: filings, results, news

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Net income −$552K −213.2% vs same quarter last year
EPS, diluted $0.00
Operating cash flow −$414.3K −72.4% vs same quarter last year
Operating income −$552K −213.2% vs same quarter last year
Net income by quarter
−$625K
−$452.3K
$464.1K
$487.6K
−$453K
−$553.7K
−$255.2K
−$552K
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
−$3M−$2M−$1M$0FY18FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearNet income
FY26−$1.7M
FY25−$1.1M
FY24−$2.1M
FY23−$348.9K
FY22−$126.5K
FY21−$302.3K
FY20−$69.6K
FY19−$78.2K
FY18-

News

No stories filed under Avai Bio yet - coverage appears here as the news feed clusters it.